$PRA

Di Piazza Samuel A Jr. sold (to issuer) $1.1M of PRA

Di Piazza Samuel A Jr. sold (to issuer) 44,952 shares of PROASSURANCE CORP (PRA) at $25.00 ($1.12M total) across 2 trades on 2026-06-26.

Original reporting
SEC EDGAR · Di Piazza Samuel A Jr.
Published Jun 26, 2026, 4:17 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 26, 2026, 4:19 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$PRA
Neutral
high confidence
Mentioned
$PRA
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$PRANeutralLow
01

Why it matters

The newest fact is the director’s $1.12M sale to the issuer at $25.00/share on 2026-06-26; it does not include any new company fundamentals.

02

Market read

Traders may note insider selling activity, but there is no accompanying fundamental catalyst to drive repricing.

03

What to watch

The filing does not provide reasons for the sale, and the transaction price ($25) may reflect the buyback/issuer process rather than market valuation at the time.

Relevance 6/10Novelty 3/10Timing: Filed 2026-06-26 (same day as transaction)

Background

The article is an SEC Form 4 insider transaction disclosure for PROASSURANCE CORP (PRA).

Company-level read

Ticker impact

$PRANeutralHigh confidence
Context

PROASSURANCE CORP director Di Piazza Samuel A Jr. sold 44,952 shares to the issuer at $25.00/share for ~$1.12M, leaving 0 shares.

Expected impact

Likely minimal near-term impact; any effect would be limited to marginal sentiment around insider selling.

Evidence & confidence

Form 4 shows a sale to issuer at a fixed price with no 10b5-1 plan and no accompanying company-specific news (earnings, guidance, deal, or investigation).

Market effects

No sector read-through; this is company-specific insider transaction data.

None indicated.

None indicated.

Counterpoint

Insider selling can sometimes signal reduced confidence, but this filing specifies a sale to the issuer, which often aligns with structured buyback mechanics rather than a bearish view.

Key entities

  • PROASSURANCE CORP

    Subject of the Form 4 insider transaction disclosure.

  • Di Piazza Samuel A Jr.

    Director who sold 44,952 shares to the issuer at $25.00/share.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$ATTOLowAI 8/10

GOLDMAN SACHS GROUP INC (WSLS OFFSHORE INVESTMENTS, SLP) purchased $10.3M of ATTO (indirect holdings)

GOLDMAN SACHS GROUP INC purchased 585,000 indirectly-held shares of Attovia Therapeutics, Inc. (ATTO) at an average of $17.58 ($17.00–$21.00, $10.28M total) across 2 trades over 2026-08-05 to 2026-08-06. Filed jointly with GOLDMAN SACHS & CO. LLC, GOLDMAN SACHS ASSET MANAGEMENT, L.P., Broad Street Principal Investments, L.L.C., WSLS OFFSHORE INVESTMENTS, SLP, West Street Life Sciences I, L.P., WSLS EMP OFFSHORE INVESTMENTS, L.P. and WSLS EMP ONSHORE INVESTMENTS, L.P..